((Cys31,Nva34)-Neuropeptide Y (27-36))2 is a covalently linked dimeric NPY fragment engineered with cysteine and norvaline substitutions. The dimeric architecture enhances avidity and allows exploration of multivalent receptor engagement. Its sequence focuses on the C-terminal recognition region critical for Y-receptor binding. Researchers apply it to probe oligomeric effects on neuropeptide signaling and receptor clustering.
CAT No: N05030
CAS No:172997-92-1
Synonyms/Alias:172997-92-1;((Cys31,Nva34)-Neuropeptide Y (27-36))2;BWX 46;EX-A9089;HY-P1325;BDBM50049745;AKOS024456920;FC109067;PD079242;CS-0029408;((Cys31, Nva 34)-Neuropeptide Y (27-36))2;(H-Tyr-Ile-Asn-Leu-Cys-Thr-Arg-Nva-Arg-Tyr-NH2)2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.